Related content

Parenteral estrogen versus total androgen ablation in the treatment of advanced prostate carcinoma: effects on overall survival and cardiovascular mortality

By Hedlund P.O.   Henriksson P.  

Urology, Vol. 55, Iss. 3, 2000-03 ,pp. : 328-332

Elsevier

Access to resources Recommend Favorite

Anemia and Cardiovascular Disease, Hospitalization, End Stage Renal Disease, and Death in Older Patients with Chronic Kidney Disease

By Li Shuling   Foley Robert   Collins Allan  

International Urology and Nephrology, Vol. 37, Iss. 2, 2005-06 ,pp. : 395-402

Springer Publishing Company

Access to resources Recommend Favorite

Cardiovascular disease in end-stage renal disease: the challenge of assessing and managing cardiac disease in dialysis patients

By Miller Lisa  

International Urology and Nephrology, Vol. 42, Iss. 4, 2010-12 ,pp. : 1007-1014

Springer Publishing Company

Access to resources Recommend Favorite

Is erectile dysfunction really a clinically useful predictor of cardiovascular disease?

By Ströberg Peter   Frick Erik   Hedelin Hans  

Scandinavian Journal of Urology and Nephrology, Vol. 39, Iss. 1, 2005-02 ,pp. : 62-65

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular events in chronic dialysis patients: emphasizing the importance of vascular disease prevention

By Paraskevas Kosmas  

International Urology and Nephrology, Vol. 42, Iss. 4, 2010-12 ,pp. : 999-1006

Springer Publishing Company

Access to resources Recommend Favorite